Eli Lilly and Company ( LLY ) will begin trading ex-dividend on February 14, 2019. A cash dividend payment of $0.645 per share is scheduled to be paid on March 08, 2019. Shareholders who purchased LLY prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 14.56% increase over prior dividend payment.
The previous trading day's last sale of LLY was $119.49, representing a -1.93% decrease from the 52 week high of $121.84 and a 60.37% increase over the 52 week low of $74.51.
LLY is a part of the Health Care sector, which includes companies such as Johnson & Johnson ( JNJ ) and Pfizer, Inc. ( PFE ). LLY's current earnings per share, an indicator of a company's profitability, is $3.13. Zacks Investment Research reports LLY's forecasted earnings growth in 2019 as .96%, compared to an industry average of -.3%.
For more information on the declaration, record and payment dates, visit the LLY Dividend History page. Our Dividend Calendar has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to LLY through an Exchange Traded Fund [ETF]?
The following ETF(s) have LLY as a top-10 holding:
- First Trust Nasdaq Pharmaceuticals ETF ( FTXH )
- iShares U.S. Pharmaceutical ETF ( IHE )
- Invesco Dynamic Pharmaceuticals ETF ( PJP )
- VanEck Vectors Pharmaceutical ETF ( PPH )
- RiverFront Dynamic US Dividend Advantage ETF ( RFDA ).
The top-performing ETF of this group is PPH with an decrease of -5.94% over the last 100 days. FTXH has the highest percent weighting of LLY at 9.38%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.